ProPhase Labs, Inc. (PRPH)
OTCMKTS · Delayed Price · Currency is USD
0.00487
+0.00027 (5.87%)
At close: Nov 13, 2026
ProPhase Labs Market Cap
ProPhase Labs has a market cap or net worth of $88.25 thousand as of November 13, 2026. It is the 51,216th most valuable company in the world and the 7,262nd biggest in the United States. Its market cap has decreased by 99.21% in one year.
Market Cap
88.25K
Enterprise Value
9.19M
Revenue
3.85M
Global Rank
Country Rank
#7,262 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since January 2, 1996, ProPhase Labs's market cap has decreased from 5.04M to 88.25K, a decrease of -98.25%. That is a compound annual growth rate of -12.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 88.25K | -95.73% |
| Dec 31, 2025 | 2.07M | -88.57% |
| Dec 31, 2024 | 18.08M | -77.84% |
| Dec 29, 2023 | 81.56M | -47.97% |
| Dec 30, 2022 | 156.75M | 41.18% |
| Dec 31, 2021 | 111.03M | 4.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Stella Diagnostics | 3.02M |
| iMD Companies | 2.28M |
| InVitro International | 1.56M |
| IDenta | 1.17M |
| Hypha Labs | 524.47K |
| NovelStem International | 385.88K |
| T2 Biosystems | 252.41K |
| Medical Imaging | 63.82K |